SCHEMBL7902869

SCHEMBL7902869

CC(=O)N1CC(=S)C[C@H]1C(=O)O.CN(C(=O)c1c(Cl)cccc1Cl)c1ccc(C[C@H](N)C(=O)O)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 5/20 0.38
ITGA4 P13612 4/20 0.38
CYP3A4 P08684 3/20 0.37
ALDH1A1 P00352 2/20 0.37
ALOX15 P16050 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HIF1A Q16665 2/20 0.37
PTGS1 P23219 2/20 0.37
ABCB11 O95342 1/20 0.37
CHRM2 P08172 1/20 0.37
ADRA2A P08913 1/20 0.37
CHRM1 P11229 1/20 0.37
ACHE P22303 1/20 0.37
OPRM1 P35372 1/20 0.37
DRD3 P35462 1/20 0.37
SLC6A3 Q01959 1/20 0.37
KCNH2 Q12809 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CYP1A2 P05177 1/20 0.37
NFKB1 P19838 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7906141 0.87 CYP3A4 (0.39) ITGA4CYP3A4ALDH1A1ALOX15SMN1; SMN2
SCHEMBL7904119 0.85 CYP3A4 (0.38) CYP3A4ALDH1A1ALOX15SMN1; SMN2HIF1A
SCHEMBL6933966 0.84 ITGB1 (0.37) ITGB1ITGA4PTGS1KMT2ATPH1
SCHEMBL7905098 0.84 ITGB1 (0.50) ITGB1ITGA4ITGB7
Phenylalanine SCHEMBL7906184 0.82 SLC7A5 (0.52) PTGS1TPH1SLC7A5ALPIPKM
SCHEMBL6933976 0.81 ITGA4 (0.46) ITGB1ITGA4
SCHEMBL7904116 0.80 SLC7A5 (0.45) CYP3A4PTGS1OPRM1CYP1A2TPH1
SCHEMBL7896702 0.80 TPH1 (0.37) ITGB1ITGA4HIF1APTGS1OPRM1
SCHEMBL7896707 0.79 GAA (0.45) ITGB1ITGA4ALDH1A1PTGS1LMNA
SCHEMBL7905211 0.79 ITGB1 (0.43) ITGB1ITGA4SMN1; SMN2TPH1ITGB7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6197794-B1 ANTIINFLAMAMTORY AGENTS; IMMUNOLOGY DISEASES CELLTECH THERAPEUTICS LIMITED (GB) 2001-03-06 US disclosed